| |
Masanori Kameoka (Original articles) |
|
 |
|
|
| |
2024:
Khairunisa, S. Q., Indriati, D. W., Megasari, N. L. A., Ueda, S., Kotaki, T., Fahmi, M., Ito, M., Rachman, B. E., Hidayati, A. N., Nasronudin and Kameoka, M. Spatial–temporal transmission dynamics of HIV-1 CRF01_AE in Indonesia. Sci. Rep. in press
Tada, T., Zhang, Y., Kong, D., Tanaka, M., Yao,W., Kameoka, M., Ueno, T., Fujita, H. and Tokunaga, K. Further characterization of the antiviral transmembrane protein MARCH8. Cells. 13(8):698, 2024.
2023:
Aoki-Utsubo, C., Hanafi, M., Armanti, D. T., Fuchino, H., Kawahara, N., Hartati, S., Widyawaruyanti, A., Sudarmono, P., Kameoka, M. and Hotta, H. Identification of an Oligostilbene, Vaticanol B, from Dryobalanops aromatica Leaves as an Antiviral Compound against the Hepatitis C Virus. Biol. Pharm. Bull. 46:1079-1087, 2023.
Takazawa, S., Kotaki, T., Nakamura, S., Utsubo, C. and Kameoka, M. Construction
of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication
analyses in biosafety level 2 facilities. Virus Res. 334:199176, 2023.
Masyeni, S, Budhitresna, A. A. G., Adiwinata, R., Wibawa, S., Nugraha, P. A., Antara, J., Asmara, D. P. G. W., Widyaningsih, P. D., Yenny, L. G. S., Widiastika, M., Kahari, S., Wardhana, C. A., Pasek, A. W., Putrawan, O., Santosa, A., Herawati, S., Arisanti, N. L. P. E., Astini, W., Fatawy, R. M., Kameoka, M. and Nelwan, E. J. The role of CD4+, CD8+, CD4+/CD8+ and neutrophile to lymphocyte ratio in predicting and determining COVID-19 severity in Indonesian patients. Trans. R. Soc. Trop. Med. Hyg. 6:trad012, 2023.
Aoki-Utsubo, C., Indrasetiawan, P., Fukano, K., Muramatsu, M., Artanti, N., Hanafi, M., Hotta, H. and Kameoka, M. Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells. Microbiol. Immunol. 67:281-292, 2023.
Bule, Y. P., Nagai, Y. and Kameoka, M. Viability and acceptability of self-sampling as a primary screening method for sexually transmitted infections in female Kobe University students. Bulletin of health sciences Kobe 38:29-43, 2023.
Khairunisa, S. Q., Megasari, N. L. A., Ueda, S., Kotaki, T., Hidayati, A. N., Nasronudin and Kameoka, M. Subtype distribution and drug resistance patterns among HIV-1 strains prevalent in Makassar, Indonesia. AIDS Res. Hum. Rertoviruses 39(3):124-129, 2023.
2022:
Nakamura, A., Kotaki, T., Nagai, Y., Takazawa, S., Tokunaga, K. and Kameoka,
M. Construction and evaluation of a self-replicative RNA vaccine against
SARS-CoV-2 using yellow fever virus replicon. PLoS ONE 17(10):e0274829,
2022.
Kotaki, T., Nagai, Y., Yamanaka, A., Konishi, E. and Kameoka, M. Japanese encephalitis DNA vaccines with epitope modification reduced the induction of cross-reactive antibodies against dengue virus and antibody-dependent enhancement of dengue virus infection. Vaccines 10(9):1411, 2022.
Takaichi, M., Osawa, K., Nomoto, R., Nakanishi, N., Kameoka, M., Miura, M., Shigemura, K., Kinoshita, S., Kitagawa, K., Uda, A., Miyara, T., Mertaniasih, N. M., Hadi, U., Raharjo, D., Yulistiani, R., Fujisawa, M., Kuntaman and Shirakawa, T. Antibiotic Resistance in Non-Typhoidal Salmonella enterica Strains Isolated from Chicken Meat in Indonesia. Pathogens 11(5):543, 2022.
Urushidani, M, Kawayoshi, A., Kotaki, T., Saeki, K., Mori, Y. and Kameoka,
M. Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous
acid solution and hydrogen peroxide solution. PLoS ONE 17(4):e0261802.
2022.
Zhang, Y., Ozono, S., Tada, T., Tobiume, M., Kameoka, M., Kishigami, S.,
Fujita, H. and Tokunaga, K. MARCH8 Targets Cytoplasmic Lysine Residues
of Various Viral Envelope Glycoproteins. Microbiol. Spectr. 10(1):e00618-21,
2022.
2021:
Kotaki, T., Kurosu, T., Grinyo-Escuer, A., Davidson, E., Churrotin, S.,
Okabayashi, T., Puiprom, O., Mulyatno, K. C., Sucipto, T. H., Doranz, B.
J., Ono, K., Soegijanto, S. and Kameoka, M. An affinity-matured human monoclonal
antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic
potency. Sci. Rep. 11:12987, 2021.
Kotaki, T., Xie, X., Shi, P.-Y. and Kameoka, M. A PCR amplicon–based SARS-CoV-2
replicon for antiviral evaluation. Sci. Rep. 11(1):2229, 2021.
Kotaki, T., Yamanaka, A., Konishi, E. and Kameoka, M. A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: a possible explanation of dengue virus evolution regarding the acquisition of N-67 glycan. Virus Res. 294:198278, 2021.
2020:
Indriati, D. W., Witaningrum, A. M., Yunifiar, M. Q., Khairunisa, S. Q., Ueda, S., Kotaki, T., Nasronudin and Kameoka, M. The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia. Acta Med. Indones. 52(4):366-374, 2020.
Ophinni, Y., Miki, S., Hayashi, Y. and Kameoka, M. Multiplexed tat-targeting CRISPR-Cas9 protects T cells from acute HIV-1 infection with inhibition of viral escape. Viruses 12(11):E1223, 2020.
Khairunisa, S. Q., Megasari, N. L. A., Ueda, S., Budiman, W., Kotaki, T., Nasronudin and Kameoka, M. 2018-2019 Update on the Molecular Epidemiology of HIV-1 in Indonesia. AIDS Res. Hum. Rertoviruses 36(11):957-963, 2020.
Khairunisa, S. Q., Megasari, N. L. A., Indriati, D. W., Kotaki, T., Natalia, D., Nasronudin and Kameoka, M. Identification of HIV-1 subtypes and drug resistance mutations among HIV-1-infected individuals residing in Pontianak, Indonesia. GERMS 10(3):174-183, 2020.
Nukuzuma, S., Nukuzuma, C., Kameoka, M., Sugiura, S., Nakamichi, K., Tasaki,
T., Hidaka, K. and Takegami, T. Characterziation of JC polyomavirus derived
from COS-IMRb cells. Jpn. J. Infect. Dis. 74(1):48-53, 2020.
Khairunisa, S. Q., Megasari, N. L. A., Rahayu, R. P., Witaningrum, A. M.,
Ueda, S., Yunifiar, M. M. Q., Indriati, D. W., Kotaki, T., Rusli, A., Nasronudin
and Kameoka, M. Detection of human immunodeficiency virus type 1 transmitted
drug resistance among treatment-naive individuals residing in Jakarta,
Indonesia. Infect. Dis. Rep. 12(s1):8740, 2020.
Sasaki, M., Kotaki, T., Khairunisa, S. Q., Tachibana, S., Ophinni, Y.,
Hayashi, Y., Nasronudin and Kameoka, M. Characterization of HIV-1 CRF01_AE
env genes derived from recently infected Indonesian individuals. AIDS Res.
Hum. Rertoviruses 36(3):242-247, 2020.
2019:
Ueda, S., Witaningrum, A. M., Khairunisa, S. Q., Kotaki, T., Motomura, K., Nasronudin and Kameoka, M. Transmission dynamics of HIV-1 subtype B strains in Indonesia. Sci. Rep. 9(1):13986, 2019.
Chaitaveep, N., Utachee, P., Tabprasit, S., Chuenchitra, T. and Kameoka, M. Comparison of antibody-dependent cellular cytotoxicity activity elicited in recent and chronic HIV-1-infected Thai individuals. Southeast Asian J. Trop. Med. Public Health 50(4):651-662, 2019.
Indrasetiawan, P., Aoki-Utsubo, C., Hanafi, M., Hartati, S., Wahyuni, T.
S., Kameoka, M., Yano, Y., Hotta, H. and Hayashi, Y. Antiviral activity
of Cananga odorata against Hepatitis B virus. Kobe J. Med. Sci. 65(2):E71-E79,
2019.
Oka, T., Negi, B. S., Ueda, S., Sasaki, M., Kotaki, T. and Kameoka, M. Genotypic characterization of HIV-1 subtype C in the central region of Nepal. AIDS Res. Hum. Rertoviruses 35(9):870-875, 2019.
Megasari, N. L. A., Oktafiani, D., Fitriana, E., Khairunisa, S. Q., Ueda,
S., Kotaki, T., Nasronudin, Soetjipto and Kameoka, M. The emergence of
HIV-1 transmitted drug resistance mutations among antiretroviral therapy-naive
individuals in Buleleng, Bali, Indonesia. Acta Med. Indones. 51(3):197-204,
2019.
Megasari, N. L. A., Oktafiani, D., Ana, E. F., Ueda, S., Kotaki, T., Nasronudin, Soetjipto and Kameoka, M. Genotypic characterization of human immunodeficiency virus type 1 isolated from ART-experienced individuals in Buleleng Regency, Bali, Indonesia. AIDS Res. Hum. Rertoviruses 35(8):769-774, 2019.
Nakashima, T., Suga, T., Kameoka, M., Ueno, M., Inahashi, Y., Matsuo, H., Iwatsuki, M., Shigemura, K., Shiomi, K., Takahashi, Y., Omura, S. and Kimura, T. New tetrahydroquinoline and indoline compounds containing a hydroxy cyclopentenone, virantmycin B and C, produced by Streptomyces sp. AM-2504. J. Antibiot. 72(3):169-173, 2019.
Ueda, S., Witaningrum, A. M., Khairunisa, S. Q., Kotaki, T., Nasronudin
and Kameoka, M. Genetic Diversity and Drug Resistance of HIV-1 Circulating
in North Sulawesi, Indonesia. AIDS Res. Hum. Retroviruses 35(4): 407-413,
2019.
2018:
Witaningrum, A. M., Khairunisa, S. Q., Ueda, S., Yunifiar, M. Q., Indriati,
D. W., Kotaki, T., Rusli, A., Nasronudin and Kameoka, M. Viral subtyping
of HIV-1 derived from infected, drug-naive individuals in Jakarta, Indonesia.
OP Conf. Ser.: Mater. Sci. Eng. 434 012321, 2018.
Nukuzuma, S., Nukuzuma, C., Kameoka, M., Sugiura, S., Nakamichi, K., Tasaki,
T., Hidaka, K. and Takegami, T. Establishment of COS-JC cells persistently
producing archetype JC polyomavirus. Microbiol. Immunol. 62(8): 524-530,
2018.
Negi, B. S., Joshi, S. K., Nakazawa, M., Kotaki, T., Bastola, A. and Kameoka, M. Impact of a massive earthquake on adherence to antiretroviral therapy, mental health, and treatment failure among people living with HIV in Nepal. PLoS ONE 13(6): e0198071, 2018.
Hidaka, K., Kimura, T., Sankaranarayanan, R., Wang, J., McDaniel, K., Kempf,
D., Kameoka, M., Adachi, M., Kuroki, R., Nguyen, J.-T., Hayashi, Y. and
Kiso, Y. Identification of highly potent human immunodeficiency virus type-1
protease inhibitors against lopinavir and darunavir resistant viruses from
allophenylnorstatine-based peptidomimetics with P2 tetrahydrofuranylglycine.
J. Med. Chem. 61(12): 5138-5153, 2018.
Ophinni, Y., Inoue, M., Kotaki, T. and Kameoka, M. CRISPR/Cas9 system targeting
regulatory genes of HIV-1 inhibits viral replication in infected T-cell
cultures. Sci. Rep. 8: 7784, 2018.
Indriati, D. W., Kotaki, T., Khairunis, S. Q., Witaningrum, A. M., Yunifiar M., M. Q., Ueda, S., Nasronudin, Purnama, A., Kurniawan, D. and Kameoka, M. Appearance of drug resistance mutations among the dominant HIV-1 subtype, CRF01_AE in Maumere, Indonesia. Curr. HIV Res. 16(2): 158-166, 2018.
Sucipto, T. H., Churrotin, S., Setyawati, H., Martak, F., Mulyatno, K. C., Amarullah, I. H., Kotaki, T., Kameoka, M., Yotopranoto, S. and Soegijanto, A. S. A new copper (II)-imidazole derivative effectively inhibits replication of DENV-2 in vero cells. Afr. J. Infect. Dis. 12(1 Suppl): 116-119, 2018.
Khairunisa, S. Q., Ueda, S., Witaningrum, A. M., Yunifiar M., M. Q., Indriati, D. W., Kotaki, T., Nasronudin and Kameoka, M. Genotypic characterization of HIV-1 prevalent in Kepulauan Riau, Indonesia. AIDS Res. Hum. Retroviruses 34(6): 555-560, 2018.
Sucipto, T. H., Kotaki, T., Mulyatno, K. C., Churrotin, S., Labiqah, A.,
Soegijanto, S. and Kameoka, M. Phylogenetic Analysis of Dengue Virus in
Bangkalan, Madura Island, East Java Province, Indonesia. J. Trop. Med.
2018: 8127093, 2018.
Khairunisa, S. Q., Masyeni, S., Witaningrum, A. M., Yunifiar M., M. Q.,
Indriati, D. W., Kotaki, T., Ueda, S., Budiyasa, D. G., Nasronudin and
Kameoka, M. Genotypic characterization of human immunodeficiency virus
type 1 isolated in Bali, Indonesia in 2016. HIV AIDS Rev. 17(2): 81-90,
2018.
Tian, Y.-S., Takagi, T., Kameoka, M. and Kawashita, N. Dengue virus and its inhibitors: a brief review. (Review) Chem. Pharm. Bull. (Tokyo) 66(3): 191-206, 2018.
Mulyatno, K. C., Kotaki, T., Yotopranoto, S., Rohmah, E. A., Churotin,
S., Sucipto, T. H., Amarullah, I. H., Wardhani, P., Soegijanto, S. and
Kameoka, M. Detection and serotyping of dengue viruses from Aedes aegypti
and Aedes albopictus (Diptera: Culicidae) collected in Surabaya, Indonesia
2008 - 2015. Jpn. J. Infect. Dis. 71(1): 58-61, 2018.
2017:
Chen, M., Aoki-Utsubo, C., Kameoka, M., Deng, L., Terada, Y., Kamitani, W., Sato, K., Koyanagi, Y., Hijikata, M., Shindo, K., Noda, T., Kohara, M. and Hotta, H. Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane. Sci. Rep. 7(1): 15931, 2017.
Yunifiar M., M. Q., Kotaki, T, Witaningrum, A. M., Khairunisa, S. Q., Indriati,
D. W., Meilani, Yeheskiel, T., Ueda, S., Nasronudin and Kameoka, M. Sero-
and molecular epidemiology of HIV-1 in Papua province, Indonesia. Acta
Med. Indones. 49(3): 205-214, 2017.
Tachibana, S., Sasaki, M., Tanaka, T., Inoue, M., Ophinni. Y., Kotaki, T. and Kameoka, M. A 2-4-amino acid deletion in the V5 Region of HIV-1 Env gp120 confers viral resistance to the broadly neutralizing human monoclonal antibody, VRC01. AIDS Res. Hum. Retroviruses 33(12): 1248-1257, 2017.
Nukuzuma, S., Nukuzuma, C., Kameoka, M., Sugiura, S., Nakamichi, K., Tasaki, T. and Takegami, T. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus. Microbiol. Immunol. 61: 232-238, 2017.
Negi, B. S., Kotaki, T., Joshi, S. K., Bastola, A., Nakazawa, M. and Kameoka, M. Genotypic characterization of human immunodeficiency virus type 1 derived from antiretroviral drug-treated individuals residing in earthquake-affected areas in Nepal. AIDS Res. Hum. Retroviruses 33: 960-965, 2017.
Inoue, M., Oyama, D., Hidaka, K. and Kameoka, M. Evaluation of novel protease inhibitors against darunavir-resistant variants of human immunodeficiency virus type 1. FEBS Open Bio 7 (1): 88-95, 2017.
2016:
Tian, Y.-S., Kawashita, N., Kameoka, M. and Takagi, T. Novel Anti-Human
Immunodeficiency Virus Compounds with Activity against Cyclophilin A: A
Look Back. J. Prev. Inf. Cntrl. 2(2): 12, 2016.
Fahmi, M. Z., Sukmayani, W., Khairunisa, S. Q., Witaningrum, A. M., Indriati,
D. W., Matondang, M. Q. Y., Chang, J.-Y., Kotaki, T. and Kameoka, M. Design
of boronic acid-attributed carbon dots on inhibits HIV-1 entry. RSC Adv.
6: 92996-93002, 2016.
Witaningrum, A. M., Kotaki, T., Khairunisa, S. Q., Yunifiar M, M. Q., Indriati,
D. W., Bramanthi, R., Nasronudin and Kameoka, M. Genotypic characterization
of human immunodeficiency virus type 1 derived from antiretroviral therapy-naïve
individuals residing in Sorong, West Papua. AIDS Res. Hum. Retroviruses
32: 812-817, 2016.
Churrotin, S., Kotaki, T., Sucipto, T. H., Ahwanah, N. L. F., Deka, P.
T., Mulyatno, K. C., Utami, D. A. P., Ranasasmita, R., Soegijanto, S. and
Kameoka, M. Dengue virus type 1 strain isolated in Indonesia shows a close
phylogenetic relationship with the strains that caused the autochthonous
dengue outbreak in Japan in 2014. Jpn. J. Infect. Dis. 69 (5): 442-444,
2016.
Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Tasaki,
T. and Takegami, T. Suppressive effect of topoisomerase inhibitors on JC
polyomavirus propagation in human neuroblastoma cells. Microbiol Immunol.
60: 253-260, 2016.
Chaitaveep, N., Utachee, P., Chuenchitra, T., Karasavvan, N., Takeda, N.
and Kameoka, M. Neutralization breadth and potency of serum derived from
recently human immunodeficiency virus type 1-infected Thai individuals.
Microbes Infect. 18:346-353, 2016.
Yamanaka, A., Oddgun, D., Chantawat, N., Okabayashi, T., Ramasoota, P.,
Churrotin, S., Kotaki, T., Kameoka, M., Soegijanto, S. and Konishi, E.
Dengue virus infection-enhancing antibody activities against Indonesian
strains in inhabitants of central Thailand. Microbes Infect. 18: 277-284,
2016.
2015:
Kotaki, T., Yamanaka, A., Mulyatno, K. C., Churrotin, S., Sucipto, T. H., Labiqah, A., Ahwanah, N. L. F., Soegijanto, S., Kameoka, M. and Konishi, E. Divergence of the dengue virus type 2 Cosmopolitan genotype associated with two predominant serotype shifts between 1 and 2 in Surabaya, Indonesia, 2008-2014. Infect. Genet. Evol. 37: 88-93, 2015.
Verathamjamras, C., Tian, Y.-S., Kawashita, N., Okamoto, K., Yasunaga, T., Ikuta, K., Motomura, K., Takeda, N., Takagi, T. and Kameoka, M. Search for Low Molecular Weight Compounds That Inhibit Human Immunodeficiency Virus Type 1 Replication. J. Infect. Dis. Ther. 3: 218, 2015.
Kotaki, T., Khairunisa, S. Q., Witaningrum, A. M., Yunifiar M., M. Q., Sukartiningrum, S. D., Noordiansyah, M., Rahayu, R. P., Nasronudin and Kameoka, M. HIV-1 Transmitted Drug Resistance Mutations among Antiretroviral Therapy-Naive Individuals in Surabaya, Indonesia. AIDS Res. Ther. 12: 5, 2015.
Nukuzuma, S., Sugiura, S., Nakamichi, K., Kameoka, M., Nukuzuma, C., Tasaki,
T. and Takegami, T. Replication of IMR-32-adapted JC virus clones in human
embryonic kidney cells. Microbiol. Immunol. 59: 238-242, 2015.
Khairunisa, S. Q., Kotaki, T., Witaningrum, A. M., Yunifiar M., M. Q.,
Sukartiningrum, S. D., Nasronudin and Kameoka, M. Appearance of Drug Resistance-Associated
Mutations in Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase
Derived from Drug-treated Indonesian Patients. AIDS Res. Hum. Retroviruses
31: 255-259, 2015.
2014:
Sucipto, T. H., Labiqah, A., Churrotin, S., Ahwanah, N., Mulyatno, K. C., Soegijanto, S., Kotaki, T., Kameoka, M. and Konishi, E. Molecular Surveillance of Dengue Virus Serotype Using Polymerase Chain Reaction in Surabaya 2013. Indonesia. J. Trop. Infect. Dis. 5: 1-4, 2014.
Kotaki, T., Yamanaka, A., Mulyatno, K. C., Churrotin, S., Labiqah, A.,
Sucipto, T. H., Soegijanto, S., Kameoka, M. and Konishi, E. Continuous
Dengue Type 1 Virus Genotype Shifts Followed by Co-circulation, Clade Shifts
and Subsequent Disappearance in Surabaya, Indonesia, 2008-2013. Infect.
Genet. Evol. 28: 48-54, 2014.
Utachee, P., Isarangkura-na-ayuthaya, P., Tokunaga, K., Ikuta, K., Takeda,
N. and Kameoka, M. Impact of amino acid substitutions in the V2 and C2
regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein
gp120 on viral neutralization susceptibility to broadly neutralizing antibodies
specific for the CD4 binding site. Retrovirology 11: 32, 2014.
Kotaki, T., Yamanaka, A., Mulyatno, K. C., Labiqah, A., Sucipto, T. H.,
Churrotin, S., Soegijanto, S., Konishi, E. and Kameoka, M. Phylogenetic
analysis of dengue virus type 3 strains primarily isolated in Surabaya,
Indonesia, in 2013. Jpn. J. Infect. Dis. 67: 227-229, 2014.
Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Tasaki,
T. and Takegami, T. TNF-α stimulates efficient JC virus replication in
neuroblastoma cells. J. Med. Virol. 86: 2026-2032, 2014.
Kotaki, T., Khairunisa, S. Q., Sukartiningrum, S. D., Witaningrum, A. M.,
Rusli, M., Diansyah, M. N., Arfijanto, M. V., Rahayu, R. P., Nasronudin
and Kameoka, M. Detection of drug resistance-associated mutations in human
immunodeficiency virus type 1 integrase derived from drug-naïve individuals
in Surabaya, Indonesia. AIDS Res. Hum. Retroviruses 30: 489-492, 2014.
Sjatha, F., Kuwahara, M., Sudiro, T. M., Kameoka, M. and Konishi, E. Evaluation
of chimeric DNA vaccines consisting of premembrane and envelope genes of
Japanese encephalitis and dengue viruses as a strategy for reduced induction
of dengue virus infection-enhancing antibody response. Microbiol. Immunol.
58: 126-134, 2014.
Chaitaveep, N., Utachee, P., Nakamura, S., Chuenchitra, T., Ekpo, P., Takeda,
N., Pattanapanyasat, K. and Kameoka, M. Characterization of human immunodeficiency
virus type 1 CRF01_AE env genes derived from recently infected Thai individuals.
Microbes Infect. 16: 142-152, 2014.
2013:
Soegijanto, S., Sari, D. W., Yamanaka, A., Kotaki, T., Kameoka, M. and Konishi, E. Awareness of using ringer lactat solution in dengue virus infection cases could induce severity. Indonesia. J. Trop. Infect. Dis. 4: 35-41, 2013.
Kotaki, T., Khairunisa, S. Q., Sukartiningrum, S. D., Arfijanto, M. V.,
Utsumi, T., Normalina, I., Handajani, R., Widiyanti, P., Rusli, M., Rahayu,
R. P., Lusida, M. I., Hayashi, Y., Nasronudin and Kameoka, M. High prevalence
of HIV-1 CRF01_AE viruses among female commercial sex workers residing
in Surabaya, Indonesia. PLoS ONE 8: e82645, 2013.
Akapirat, S., Avihingsanon, A., Ananworanich, J., Schuetz, A., Ramasoota,
P., Luplertlop, N., Ono, K., Ikuta, K., Utachee, P., Kameoka, M. and Leaungwutiwong,
P. Variables influencing anti-human immunodeficiency virus type 1neutralizing
monoclonalantibody (NHMAb) production among infected Thais. Southeast Asian
J. Trop. Med. Public Health 44: 825-841, 2013.
Sapsutthipas, S., Tsuchiya, N., Pathipavanich, P., Ariyoshi, K., Sawanpanyalert,
P., Takeda, N., Panasda Isarangkura-na-ayuthaya, P. and Kameoka, M. CRF01_AE-specific
neutralizing activity observed in plasma derived from HIV-1-infected Thai
patients residing in northern Thailand: comparison of neutralizing breadth
and potency between plasma derived from rapid and slow progressors. PLoS
ONE 8: e53920, 2013.
Nukuzuma, S., Kameoka, M., Sugiura, S., Nakamichi, K., Nukuzuma, C. and
Takegami, T. Suppressive effect of PARP-1 inhibitor on JC virus replication
in vitro. J. Med. Virol. 85: 132-137, 2013.
Tian, Y.-S., Verathamjamras, C., Kawashita, N., Okamoto K., Yasunaga, T.,
Ikuta, K., Kameoka, M. and Takagi, T. Discovery of novel low-molecular-weight
HIV-1 inhibitors interacting with cyclophilin A using in silico screening
and biological evaluations. J. Mol. Model. 19: 465-475, 2013.
2012:
Li, Y. G., Siripanyaphinyo. U., Tumkosit, U., Noranate, N., A. Nuegoonpipat, A., Pan. Y., Kameoka, M., Takeshi, K., Ikuta, K., Takeda, N. and Anantapreecha, S. Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells. Virol. J. 9: 114, 2012.
Nukuzuma, S., Kameoka, M., Sugiura, S., Nakamichi, K., Nukuzuma, C., Miyoshi, I. and Takegami, T. Exogenous human immunodeficiency virus-1 protein, Tat, enhances replication of JC virus efficiently in neuroblastoma cell lines. J. Med. Virol. 84: 555-561, 2012.
2011:
Boonchawalit, S., Jullaksorn, D., Uttiyoung, J., Yowang, A., Krathong, N., Chautrakul, S., Yamashita, A., Ikuta, K., Roobsoong, A., Kanitvittaya, S., Sawanpanyalert, P. and Kameoka, M. Molecular evolution of HIV-1 CRF01_AE Env in Thai patients. PLoS ONE 6: e27098, 2011.
Sapsutthipas, S., Kitagawa, Y., Tokunaga, K., Ikuta, K. and Kameoka, M. Viral factors involved in adapter-related protein complex 2 alpha 1 subunit-mediated regulation of human immunodeficiency virus type 1 replication. Southeast Asian J. Trop. Med. Public Health 42: 311-319, 2011.
2010:
Isarangkura-na-ayuthaya, P., Kaewnoo, W., Auwanit, W., de Silva, U. C., Ikuta, K., Sawanpanyalert, P. and Kameoka, M. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 CRF01_AE integrase derived from drug-naive Thai patients. AIDS Res. Hum. Retroviruses 26: 1341-1343, 2010.
Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Miyoshi, I. and Takegami, T. Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiol. Immunol. 54: 758?762, 2010.
Soonthornsata, B., Tian, Y.-S., Utachee, P., Sapsutthipas, S., Isarangkura-na-ayuthaya, P., Auwanit, W., Takagi, T., Ikuta, K., Sawanpanyalert, P., Kawashita, N. and Kameoka, M. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41. Virology 405: 157-164, 2010.
Kameoka, M., Isarangkura-na-ayuthaya, P., Kameoka, Y., Sapsutthipas, S, Soonthornsata, B., Nakamura, S., Tokunaga, K., Sawanpanyalert, P., Ikuta, K. and Auwanit, W. The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors. Virology 405: 129-138, 2010.
Li, Y. G., Chittaganpitch, M., Waicharoen, S., Kanai, Y., Bai, G. R., Warachit, J., Kameoka, M., Takeda, N., Ikuta, K. and Sawanpanyalert, P. Characterization of H5N1 influenza viruses in vitro isolated from humans. Virol. J. 7: 112, 2010.
Utachee, P., Nakamura, S., Isarangkura-na-ayuthaya, P., Tokunaga, K., Sawanpanyalert, P., Ikuta, K., Auwanit, W. and Kameoka, M. Two N-linked glycosylation sites in V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for CD4 binding domain. J. Virol. 84: 4311-4320, 2010.
Jullaksorn, D., Boonchawalit, T., Uttiyoung, J., Soonthornsata, B., Yowang, A., Krathong, N., Chautrakul, S., Ikuta, K., Roobsoong, A., Kanitvittaya, S., Sawanpanyalert, P. and Kameoka, M. Sustained appearance of drug resistance-associated mutations in CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients. Southeast Asian J. Trop. Med. Public Health 41: 347-357, 2010.
de Silva, U. C., Warachit, J., Sattagowit, N., Jirapongwattana, C., Panthong, S., Utachee, P., Yasunaga, T., Ikuta, K., Kameoka, M. and Boonsathorn, N. Genotypic characterization of HIV-1 env gp160 sequences from three regions in Thailand. AIDS Res. Hum. Retroviruses 26: 223-227, 2010.
Pongsuwannna, Y., Guntapong, R., Tacharoenmuang, R., Prapanpoj, M., Kameoka, M. and Taniguchi, K. A long-term survey on the distribution of the human G type rotavirus in Thailand. J. Med. Virol. 82: 157-163, 2010.
2009:
Nukuzuma, S., Kameoka, M., Sugiura, S., Nakamichi, K., Nukuzuma, C., Miyoshi, I. and Takegami, T. Archetype JC virus efficiently propagates in kidney-derived cells stably expressing HIV-1 Tat. Microbiol. Immunol. 53: 621-628, 2009.
Jinnopat, P., Isarangkura-na-ayuthaya, P., Utachee, P., Kitagawa, Y., de Silva, U. C., Siripanyaphinyo, U., Kameoka, Y., Tokunaga, K., Sawanpanyalert, P., Ikuta, K., Auwanit, W. and Kameoka, M. Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE strains on Drug Susceptibility of Virus to Protease Inhibitors. J. Acquir. Immune Defic. Syndr. 52: 320-328, 2009.
Kameoka, M., Kameoka, Y., Uthachee, P., Kurosu, T., Sawanpanyalert, P., Ikuta, K. and Auwanit, W. RNA Interference Directed Against Axin1 Up-regulates Human Immunodeficiency Virus Type 1 Gene Expression by Activating Wnt Signaling Pathway in HeLa-Derived J111 Cells. AIDS Res. Hum. Retroviruses 25: 1005-1011, 2009.
Auwanit, W., Isarangkura-na-ayuthaya, P., Kasornpikul, D., Ikuta, K., Sawanpanyalert, P. and Kameoka, M. Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand. AIDS Res. Hum. Retroviruses 25: 625-631, 2009.
Siripanyaphinyo, U., Laohasinnarong, D., Siripanee, J., Kaeoket, K., Kameoka, M., Ikuta, K. and Sawanpanyalert, P. Full-length sequence of genotype 3 hepatitis E virus derived from a pig in Thailand. J. Med. Virol. 81: 657-664, 2009.
Utachee, P., Jinnopat, P., Isarangkura-na-ayuthaya, P., de Silva, U. C., Nakamura, S., Siripanyaphinyo, U., Wichukchinda, N., Tokunaga, K., Yasunaga, T., Sawanpanyalert, P., Auwanit, W., Ikuta, K. and Kameoka, M. Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient residing in central Thailand. Microbes Infect. 11: 334-343, 2009.
Utachee, P., Jinnopat, P., Isarangkura-na-ayuthaya, P., de Silva, U. C., Nakamura, S., Siripanyaphinyo, U., Wichukchinda, N., Tokunaga, K., Yasunaga, T., Sawanpanyalert, P., Auwanit, W., Ikuta, K. and Kameoka, M. Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand. AIDS Res. Hum. Retroviruses 25: 229-236, 2009.
2008:
Iwabu, Y., Mizuta, H., Kawase, M., Kameoka, M., Goto, T. and Ikuta, K. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Microbes Infect. 10: 504-513, 2008.
Kitagawa, Y., Kameoka, M., Shoji-Kawata, S., Iwabu, Y., Mizuta, H., Tokunaga, K., Fujino, M., Natori, Y.,Yura, Y. and Ikuta, K. Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome. Virology 373: 171-180, 2008.
2007:
Shoji-Kawata, S., Zhong, Q., Kameoka, M., Iwabu, Y., Sapsutthipas, S., Luftig, R. B. and Ikuta, K. The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells. Virology 368: 191-204, 2007.
Kameoka, M., Kitagawa, Y., Utachee, P., Jinnopat, P., Dhepakson, P., Isarangkura-na-ayuthaya, P., Tokunaga, K., Sato, H., Komano, J., Yamamoto, N., Oguchi, S., Natori, Y. and Ikuta, K. Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes. Biochem. Biophys. Res. Commun. 359: 729-734, 2007.
Lau, T. S., Li, Y. G., Kameoka, M., Ng, T. B. and Wan, D. C.-C. Suppression of HIV Replication using RNA Interference against HIV-1 Integrase. FEBS lett. 581: 3253-3259, 2007.
2006:
Iwabu, Y., Goto, T., Tsuji, S., Warachit, J., Li,G. M., Shoji, S., Kameoka, M. and Ikuta, K. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1. Microbes Infect. 8: 1773-1782, 2006.
Tanaka, Y., Ota, K., Kameoka, M., Itaya, A. and Yoshihara, K. Up-regulation of NF-kB-responsive gene expression by DNp73a in p53 null cells. Exp. Cell Res. 312: 1254-1264, 2006.
2005:
Kameoka, M., Nukuzuma, S., Itaya, A., Tanaka, Y., Ota, K., Inada, Y., Ikuta, K. and Yoshihara, K. Poly(ADP-ribose)polymerase-1 is required for integration of the human immunodeficiency virus type 1 genome near centromeric alphoid DNA in human and murine cells. Biochem. Biophys. Res. Commun. 334: 412-417, 2005.
Li, Y. G, Iwabu, Y., Warachit, J., Kinomoto, M., Ibrahim, M. S., Tsuji, S., Mukai, T., Kameoka, M., Tokunaga, K., Sata, T. and Ikuta, K. Interleukin-4 Up-Regulates T-Tropic Human Immunodeficiency Virus Type 1 Transcription in Primary CD4(+) CD38(+) T-Lymphocyte Subset. Microbiol. Immunol. 49 (2): 155-165, 2005.
2004:
Kameoka, M., Nukuzuma, S., Itaya, A., Tanaka, Y., Ota, K., Ikuta, K., and Yoshihara, K. RNA Interference directed against poly(ADP-ribose) polymerase-1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J. Virol. 78: 8931-8934, 2004.
Tanaka, Y., Kameoka, M., Itaya, A., Ota, K. and Yoshihara, K. Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73a. Biochem. Biophys. Res. Commun. 317: 865-872, 2004.
Liang, C., Hu, J., Russell, R. S., Kameoka, M. and Wainberg, M. A. Spliced human immunodeficiency virus type 1 RNA is reverse transcribed into cDNA within infected cells. AIDS Res. Hum. Retroviruses 20: 203-211, 2004.
2003:
Ota, K., Kameoka, M., Tanaka, Y., Itaya, A. and Yoshihara, K. Expression of histone acetyltransferases was down-regulated in Poly(ADP-ribose) polymerase-1-deficient murine cells. Biochem. Biophys. Res. Commun. 310: 312-317, 2003
Guo, X., Kameoka, M., Wei, X., Roques, B., Gotte, M., Liang, C. and Wainberg, M. A. Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences. Virology 307: 154-163, 2003.
2002:
Kameoka, M., Morgan, M., Binette, M., Russell, R. S., Rong, L., Guo, X., Mouland, A., Kleiman, L., Liang, C. and Wainberg, M. A. The Tat protein of human immunodeficiency virus type1 can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. J. Virol. 76: 3637-3645, 2002.
Ota K., Yakovlev A.G., Itaya A., Kameoka M., Tanaka Y. and Yoshihara K. Alteration of Apoptotic Protease-Activating Factor-1 (APAF-1)-Dependent Apoptotic Pathway During Development of Rat Brain and Liver. J. Biochem. (Tokyo) 131: 131-135, 2002.
2001:
Kameoka, M., Rong, L., Gotte, M., Liang, C., Russell, R. S. and Wainberg, M. A. A Role for the Tat Protein of HIV-1 in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication. J. Virol. 75: 2675-2683, 2001.
Gotte, M., Kameoka, M., McLellan, N., Cellai, L. and Wainberg, M. A. Analysis of efficiency and fidelity of HIV-1 plus-strand DNA synthesis reveals a novel rate-limiting step during retroviral reverse transcription. J. Biol. Chem. 276: 6711-6719, 2001.
2000:
Bahmani, M. K., Kameoka, M., Goto, T., Sano, K., Luftig, R. B. and Ikuta, K. Fusion of uninfected T-cells occurs with immature HIV-1 protease-mutant, but not morphologically similar protease inhibitor derived particles. Virus Res. 66: 131-137, 2000.
Kameoka, M., Ota, K., Tetsuka, T., Tanaka, Y., Itaya, A., Okamoto, T. and Yoshihara, K. Evidence for regulation of NF-kB by poly (ADP-ribose) polymerase. Biochem. J. 346: 641-649, 2000.
Suzuki, S., Tobiume, M., Kameoka, M., Sato, K., Takahashi, T. A., Mukai, T. and Ikuta, K. Exposure of normal monocyte-derived dendritic cells to human immunodeficiency virus type-1 particles leads to the induction of apoptosis in co-cultured CD4+ as well as CD8+ T cells. Microbiol. Immunol. 44: 111-121, 2000.
1999:
Kameoka, M., Tanaka, Y., Ota, K., Itaya, A. and Yoshihara, K. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function. Biochem. Biophys. Res. Commun. 262: 285-289, 1999.
Kameoka, M., Tanaka, Y., Ota, K., Itaya, A., Yamamoto, K. and Yoshihara, K. HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro. Biochem. Biophys. Res. Commun. 261: 90-94, 1999.
Tanaka, Y., Kameoka, M., Ota, K., Itaya, A., Ikuta, K. and Yoshihara, K. Establishment of persistent infection with HIV-1 abrogates caspase-3-dependent apoptotic signaling pathway in U937 cells. Exp. Cell Res. 247: 514-524, 1999.
1998:
Kameoka, M., Auwanit, W., Suzuki, S., Horikoshi, H., Khlai-Khlam, N., Meguro, T., Yamada, K., Tanaka, Y., Yoshihara, K., Luftig, R. B. and Ikuta, K. A specific T-cell subset with CD4+/CD38- markers derived from HIV-1 carriers induces apoptosis in healthy donor-derived T-lymphocytes. Virus Res. 56: 115-122, 1998.
Tobiume, M., Fujinaga, K., Kameoka, M., Kimura, T., Nakaya, T., Yamada, T. and Ikuta, K. Dependence of host cell cycle for activation of HIV-1 gene expression from latency. J. Gen. Virol. 79: 1363-1371, 1998.
1997:
Ikuta, K., Kameoka, M. and Luftig, R. B. AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles. Virus Res. 52: 145-156, 1997.
Suzuki, S., Kameoka, M., Nakaya, T., Kimura, T., Nishi, N. and Ikuta, K. Superoxide generation by monocytes following infection with human cytomegalovirus. Immunopharmacol. 37: 185-190, 1997.
Yoshihara, K., Ide, T., Ota, K., Tanaka, Y., Kameoka, M., Kumamoto, N. and Koide, S.S. Anti Ca2+, Mg2+-dependent endonuclease antibody which specifically detects this class of chromatin bound endonuclease from various tissues. Biochem. Biophys. Res. Commun. 236: 423-426, 1997.
Kameoka, M., Suzuki, S., Kimura, T., Fujinaga, K., Auwanit, W., Luftig, R. B. and Ikuta, K. Exposure of resting peripheral blood T-cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells. Int. Immunol. 9: 1453-1462, 1997.
Bahmani, M. K., Kameoka, M., Nakaya, T., Fujinaga, K., Zhong, Q., Takahashi, H., Nakano, T., Nakai, M., Ueda, S., Jones, I.M., Luftig, R. B. and Ikuta, K. Production of doughnut-shaped, protease-defective particles from a human T cell clone carrying a provirus with specific mutations in the env, pol, vpr, and nef genes. AIDS res. hum. retroviruses 13: 523-526, 1997.
Zheng, Y.-H. Nakaya, T., Sentsui, H., Kameoka, M., Kishi, M., Hagiwara, K., Takahashi, H., Kono, Y. and Ikuta, K. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anemia virus occurred during febrile episodes in an experimentally infected horses. J. Gen. Virol. 78: 807-820, 1997.
Kameoka, M., Kimura, T., Zheng, Y.-H. Suzuki, S., Fujinaga, K., Luftig, R. B. and Ikuta, K. Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than dose wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. J. Clin. Microbiol. 35: 41-47, 1997.
Zhong, Q., Nakaya, T., Tateno, Y., Fujinaga, K., Kameoka, M., Tateno, M. and Ikuta, K. A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci. Vaccine 15: 497-510, 1997.
Nakamura, Y., Kameoka, M., Tobiume, M., Kaya, M., Ohki, K., Yamada, T. and Ikuta, K. A chain section containing epitopes for cytotoxic T,B and helper T cells within a higyly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 15: 489-496, 1997.
1996:
Kameoka, M., Kimura, T., Zhong, Q., Zheng, Y.-H., Luftig, R. B. and Ikuta, K. Induction of apoptosis by protease-defective particles of human immunodeficiency virus type-1 is specific to a subset of U937-derived subclones. Int. Immunol. 8: 1687-1697, 1996.
Kameoka, M., Okada, Y., Tobiume, M., Kimura, T. and Ikuta, K. Intracellelar glutathione as a possible direct blocker for HIV-1 reserse transcription. AIDS res. hum. retroviruses 12: 1635-1638, 1996.
Kameoka, M., Kimura, T., Okada, Y., Fujinaga, K., Nakaya, T., Takahashi, H., Kishi, M. and Ikuta, K. High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA. Virus Genes 12: 117-129, 1996.
Wada, N., Ohara, N., Kameoka, M., Nishino, Y., Matsumoto, S., Nishiyama, T., Naito, M., Yukitake, H., Okada, Y., Ikuta, K. and Yamada, T. Long-lasting immune response induced by recombinant Bacillus Calmette-Guerin (BCG) secretion system. Scand. J. Immunol. 43: 202-209, 1996.
1995:
Okada, Y., Kameoka, M., Kimura, T., Azuma, I. and Ikuta, K. Stimulation of human immunodeficiency virus type 1 infected cells with superoxide enhances the chemotactic motile response of CD4+ human T cells: implication for virus transmission by cell-to-cell interaction. Immunopharmacol. 31: 73-84, 1995.
Fujinaga, K., Zhong, Q., Nakaya, T., Kameoka, M., Megro, T., Yamada, K. and Ikuta, K. Extracellular Nef protein regulates productive HIV-1 infection from latency. J.Immunol. 155: 5289-5298, 1995
Tanaka, Y., Yoshihara, K., Tohno, Y., Kojima, K., Kameoka, M. and Kamiya,T. Inhibition and down-regulation of poly(ADP-ribose) polymerase results in a marked resistance of HL-60 cells to various apoptosis-inducers. Cell.Mol.Biol. 41: 771-781, 1995
Tanaka, Y., Yoshihara, K., Kojima, K., Itaya, A., Kameoka, M., Ikuta, K. and Kamiya, T. Poly(ADP-ribose) polymerase activity in various U937 cell subclones with different susceptibility to HIV-1 infection : Its dramatic decrease following persistent virus infection. Biochem. Biophys. Res. Commun. 213: 161-168, 1995.
Kameoka, M., Kimura, T., Okada, Y., Fujinaga, K., Nakaya, T., kishi, M. and Ikuta, K. High susceptibility of U937-derived subclone to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation. Immunopharmacol. 30: 89-101, 1995.
Okada, Y., Kimura, T., Kameoka, M., Kishi, M., Azuma, I. and Ikuta, K. Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1. Immunopharmacol. 30: 27-39, 1995.
1994:
Otake, K., Fujii, Y., Nakaya, T., Nishino, Y., Zhong, Q., Fujinaga, K., Kameoka, M., Ohki, K. and Ikuta, K. The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells. J. Immunol. 153: 5826-5837, 1994.
Nishino, Y., Kameoka, M., Okada, Y., Zhong Q., Kimura, T., Azuma, I. and Ikuta, K. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24. Vaccine 12: 485-491, 1994.
Kameoka, M., Nishino, Y., Matsuo, K., Ohara, N., Kimura, T., Yamazaki, A., Yamada, T. and Ikuta, K. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular α antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 12: 153-158, 1994.
1993:
Kameoka, M., Kimura, T. and Ikuta, K. Superoxide enhances the spread of HIV-1 infection by cell-to-cell transmission. FEBS Lett. 331: 182-186, 1993.
Kimura, T., Kameoka, M. and Ikuta, K. Amplification of superoxide anion generation in phagocytic cells by HIV-1 infection. FEBS Lett. 326: 232-236, 1993. |
|
| |
|
|
| |
|
|
| |
|
|
|
